Telcare, a US-based provider of monitors that let people know their blood-sugar levels, has raised $25.5m in its series B round from a consortium including chip maker Qualcomm’s $100m Life corporate venturing fund. Venture capital firm Sequoia Capital led the B round, which followed a $4.5m A round from a consortium also including Qualcomm at…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
